Welcome to Pedagogy   |   Sign In

The War on Drugs Becomes the War on Patients in Pain

We are a nation at war with multiple enemies that threaten the health and well-being of our people. Some of these enemies include worsening epidemics of obesity, diabetes and drug abuse. While we typically do not think of being at “war” with obesity and diabetes, we have been waging the war on drugs for several decades.

I will leave it to others to decide if the war on drugs has been successful, but I do know that this “war” has had some unintended victims: patients in pain. We treat many patients with pain in the long-term care/post-acute (LTC/PA) facilities we serve. Some of these patients suffer from acute pain either from trauma due to accidents or from recent surgeries including orthopedic procedures. Others come to us with a long history of chronic pain. Our primary goal is to help these patients improve or maintain the highest, practicable level of physical and mental function.

Recently, the Drug Enforcement Administration has proposed moving hydrocodone/acetaminophen products (i.e. Lortab, Vicodin) from Schedule III to Schedule II which would significantly impact the way these products are ordered, dispensed, and administered to LTC/PA patients. The DEA does not recognize chart orders as valid prescriptions in the LTC/PA setting nor does it recognize LTC/PA nurses as agents of the prescriber unless they are employees of the prescriber’s practice. This means that prescribers must mail or fax new or renewal orders for Schedule II drugs to the pharmacy at least every 60 days. By comparison, Schedule III drugs may be called to the pharmacy and each prescription can provide medication to a patient for up to six months.

Hydrocodone/acetaminophen is a very effective and relatively safe opioid pain medication that is widely used in the LTC/PA setting. Restricting these products to Schedule II has the potential to delay effective pain management, especially for patients discharged from acute care hospitals.

However, this concern must be balanced against the potential reduction in deaths and suffering caused by the abuse of these products in the community. The DEA believes that the potential reduction in availability of these products for diversion and abuse more than justifies this action.

Only time will tell who is right, but in the meantime, I urge the DEA to recognize that patients in LTC/PA facilities need the same access to effective pain management as those treated in acute care hospitals where chart orders are recognized as valid prescriptions and nurses can act as agents of the prescriber regardless of employment status.

Original post may be found on alixaRX.com blog.

  
Guest Post by Dr. Albert Barber:

Dr. Barber is a Director of Pharmacy Services for alixaRx, a national long-term care pharmacy. He is responsible for clinical education and works on regulatory affairs for alixaRx. Previously he was Director of Pharmacy for Golden Living, a provider of long-term and post-acute care for residents needing skilled nursing and assisted living services. He currently serves as the clinical consultant pharmacist for Golden Living Kirtland, Ohio. Al also provides drug therapy consultations to seniors living in the community through his consulting practice, Clinical Rx Consulting. Primary areas of practice include: post-acute care, geriatrics, psychopharmacology, and pain management.

Al is a Past-President of the American Society of Consultant Pharmacists (ASCP). He also serves as national faculty for the APhA Medication Therapy Management Certificate Program.



Pedagogy offers several online continuing education and inservice courses dealing with the management of pain.

Current Concepts in Adult Pain Management: An online course for the licensed nurse.

Pain Care: An inservice for certified nurse assitants, home care aides and caregivers.

Current Concepts in Adult Pain Management for Administrators: accredited for long term care and assisted living facility administrators.

Click on each title to learn more.
Posted: 12/18/2014 9:37:58 AM
Comments
Comments
Blog post currently doesn't have any comments.
Leave comment




 Security code
Copyright © 2018 Pedagogy, Inc. All Rights Reserved.



Powered by Kentico